112 related articles for article (PubMed ID: 7192287)
1. Combination chemotherapy with ifosfamide and cis-dichlorodiammineplatinum (II) in advanced malignant melanoma.
Becher R; Seeber S; Schmidt CG
J Cancer Res Clin Oncol; 1980; 97(3):301-6. PubMed ID: 7192287
[TBL] [Abstract][Full Text] [Related]
2. [Combination chemotherapy with cis-dichloro-diammineplatinum (II) and ifosfamide in malignant melanomas (author's transl)].
Balda BR; Jehn U; Klövekorn W; Wohlrab A
Klin Wochenschr; 1981 Jul; 59(14):781-6. PubMed ID: 7196477
[TBL] [Abstract][Full Text] [Related]
3. Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon-alpha after intravenous dacarbazine and carboplatin or intravenous dacarbazine, cisplatin, carmustine and tamoxifen.
Atzpodien J; Lopez Hänninen E; Kirchner H; Franzke A; Körfer A; Volkenandt M; Duensing S; Schomburg A; Chaitchik S; Poliwoda H
Eur J Cancer; 1995 Jun; 31A(6):876-81. PubMed ID: 7646914
[TBL] [Abstract][Full Text] [Related]
4. [Combined chemotherapy of metastasing melanoblastoma using ifosfamide and cis-platinum (II)-diamminodichloride (author's transl)].
Schmidt CG; Becher R
Dtsch Med Wochenschr; 1979 Jun; 104(24):872-5. PubMed ID: 446309
[TBL] [Abstract][Full Text] [Related]
5. Cis-dichlorodiammineplatinum(II) alone and combined with DTIC for treatment of disseminated malignant melanoma.
Goodnight JE; Moseley HS; Eilber FR; Sarna G; Morton DL
Cancer Treat Rep; 1979; 63(11-12):2005-7. PubMed ID: 393385
[TBL] [Abstract][Full Text] [Related]
6. [Chemo-/immunotherapy in advanced malignant melanoma: carboplatin and DTIC or cisplatin, dtic, bcnu and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha-2a].
Kirchner HH; Atzpodien J; Poliwoda H
Med Klin (Munich); 1996 Apr; 91 Suppl 3():44-9. PubMed ID: 8692119
[TBL] [Abstract][Full Text] [Related]
7. cis-Dichlorodiammineplatinum(II) and DTIC in malignant melanoma.
Karakousis CP; Getaz EP; Bjornsson S; Henderson ES; Irequi M; Martinez L; Ospina J; Cavins J; Preisler H; Holyoke E; Holtermann O
Cancer Treat Rep; 1979; 63(11-12):2009-10. PubMed ID: 393386
[TBL] [Abstract][Full Text] [Related]
8. [Chemotherapy of malignant melanoma with cis-diaminodichloroplatinum and ifosfamid (author's transl)].
Berdel WE; Fink U; Emmerich B; Maubach PA; Busch U; Remy W; Rastetter J
Dtsch Med Wochenschr; 1982 Jan; 107(1):26-8. PubMed ID: 7198963
[No Abstract] [Full Text] [Related]
9. High-dose ifosfamide in advanced osteosarcoma.
Marti C; Kroner T; Remagen W; Berchtold W; Cserhati M; Varini M
Cancer Treat Rep; 1985 Jan; 69(1):115-7. PubMed ID: 3855382
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of ICRF-159 versus combination cis-dichlorodiammineplatinum(II) and DTIC in patients with disseminated malignant melanoma.
Ahmann DL; Edmonson JH; Frytak S; Kvols LK; Bisel HF; Rubin J
Cancer Treat Rep; 1978 Jan; 62(1):151-3. PubMed ID: 626995
[No Abstract] [Full Text] [Related]
11. High-dose, double alkylating agent chemotherapy with DTIC, melphalan, or ifosfamide and marrow rescue for metastatic malignant melanoma.
Thatcher D; Lind M; Morgenstern G; Carr T; Chadwick G; Jones R; Craig P
Cancer; 1989 Apr; 63(7):1296-302. PubMed ID: 2646005
[TBL] [Abstract][Full Text] [Related]
12. Combined DTIC and cis-dichlorodiammineplatinum(II) therapy for patients with disseminated melanoma: a Northern California Oncology Group study.
Friedman MA; Kaufman DA; Williams JE; Resser KJ; Rosenbaum EH; Cohen RJ; Glassberg AB; Blume MR; Gershow J; Chan EY
Cancer Treat Rep; 1979 Mar; 63(3):493-5. PubMed ID: 371802
[No Abstract] [Full Text] [Related]
13. Combination chemotherapy in metastatic malignant melanoma: a randomized study of three DTIC-containing combination.
Wittes RE; Wittes JT; Golbey RB
Cancer; 1978 Feb; 41(2):415-21. PubMed ID: 343907
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy of disseminated malignant melanoma with imidazol carboxamide (DTIC) and cyclophosphamide. Preliminary results.
Rudolf Z; Plesnicar S
Anticancer Res; 1982; 2(1-2):37-9. PubMed ID: 7051959
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazine.
Propper DJ; Braybrooke JP; Levitt NC; O'Byrne K; Christodoulos K; Han C; Talbot DC; Ganesan TS; Harris AL
Br J Cancer; 2000 Jun; 82(11):1759-63. PubMed ID: 10839287
[TBL] [Abstract][Full Text] [Related]
16. Studies on drug resistance in a human melanoma xenograft system.
Osieka R
Cancer Treat Rev; 1984 Mar; 11 Suppl A():85-98. PubMed ID: 6539651
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of high-dose ifosfamide as a single agent and in combination with cisplatin in the treatment of advanced and/or recurrent squamous cell carcinoma of head and neck.
Pai VR; Parikh DM; Mazumdar AT; Rao RS
Oncology; 1993; 50(2):86-91. PubMed ID: 8451041
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma. A multicenter phase II study of the Italian Cooperative Oncology Group.
Daponte A; Ascierto PA; Gravina A; Melucci MT; Palmieri G; Comella P; Cellerino R; DeLena M; Marini G; Comella G;
Cancer; 2000 Dec; 89(12):2630-6. PubMed ID: 11135225
[TBL] [Abstract][Full Text] [Related]
19. High-dose cisplatin plus dacarbazine in the treatment of metastatic melanoma.
Murren JR; DeRosa W; Durivage HJ; Davis C; Makuch R; Portlock CS
Cancer; 1991 Mar; 67(6):1514-7. PubMed ID: 2001539
[TBL] [Abstract][Full Text] [Related]
20. Salvage chemotherapy for lymphoma with VP-16, ifosfamide, and cisplatin.
Nichols CR; Loehrer PJ; Greist A; Kubilis PS; Hoffman R
Med Pediatr Oncol; 1988; 16(1):12-6. PubMed ID: 3340061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
